One day after AstraZeneca suspended its COVID-19 tests, Serum Institute of India is under fire for failing to pause its clinical trial in India. IBS is conducting phase 3 trials in people in India involving UK-based AstraZeneca’s COVID-19 vaccine candidate. However, Pune-based SII has said there have been no “problems” …
Read More »Live updates of the day 169 of the closure of the coronavirus in India | Red Line, Violet Line, Green Line resume services in New Delhi after 172 days
